CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MRK

Lenvatinib

Phase 3
MERCK (MRK)

Phase 3

Development Phase

4

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Nov '27
MRKPhase 2

Lenvatinib Phase 2 Est. Readout

Lenvatinib
Nov 2027~
CT.gov
00%
Mar '27
MRKPhase 2

Lenvatinib Phase 2 Est. Readout

Lenvatinib
Mar 2027~
CT.gov
00%
Mar '27
MRKPhase 2

Lenvatinib Phase 2 Est. Readout

Lenvatinib
Mar 2027~
CT.gov
00%
Dec '26
MRKPhase 2

Lenvatinib Phase 2 Est. Readout

Lenvatinib
Dec 2026~
CT.gov
00%
Drug Information

Target Indication

Non-small Cell Lung Cancer

Clinical Trial

NCT03829332

Last updated: 12/16/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.